Frontiers in Cell and Developmental Biology (Nov 2024)

Multicellular 3D models to study myocardial ischemia–reperfusion injury

  • Merel Peletier,
  • Merel Peletier,
  • Xiaohan Zhang,
  • Xiaohan Zhang,
  • Scarlett Klein,
  • Scarlett Klein,
  • Jeffrey Kroon,
  • Jeffrey Kroon,
  • Jeffrey Kroon,
  • Jeffrey Kroon

DOI
https://doi.org/10.3389/fcell.2024.1494911
Journal volume & issue
Vol. 12

Abstract

Read online

Coronary heart disease is a major global health threat, with acute myocardial ischemia–reperfusion injury (IRI) being a major contributor to myocardial damage following an ischemic event. IRI occurs when blood flow to ischemic tissues is restored and exacerbates the cellular damage caused by ischemia/hypoxia. Although animal studies investigating IRI have provided valuable insights, their translation into clinical outcomes has been limited, and translation into medical practice remains cumbersome. Recent advancements in engineered three-dimensional human in vitro models could offer a promising avenue to bridge the “therapeutic valley of death” from bench to bedside, enhancing the understanding of IRI pathology. This review summarizes the current state-of-the-art cardiovascular 3D models, including spheroids, organoids, engineered cardiac microtissues, and organ-on-a-chip systems. We provide an overview of their advantages and limitations in the context of IRI, with a particular emphasis on the crucial roles of cell–cell communication and the multi-omics approaches to enhance our understanding of the pathophysiological processes involved in IRI and its treatment. Finally, we discuss currently available multicellular human 3D models of IRI.

Keywords